The impact of generic-only drug benefits on patients' use of inhaled corticosteroids in a Medicare population with asthma

[1]  H. Cannon.  MedPAC Releases March 2008 Report to the Congress: Medicare Payment Policy , 2008 .

[2]  Jarvis T. Chen,et al.  Comparing individual- and area-based socioeconomic measures for the surveillance of health disparities: A multilevel analysis of Massachusetts births, 1989-1991. , 2006, American journal of epidemiology.

[3]  B. Bender,et al.  Adherence and persistence with fluticasone propionate/salmeterol combination therapy. , 2006, The Journal of allergy and clinical immunology.

[4]  R. Horne.  Compliance, adherence, and concordance: implications for asthma treatment. , 2006, Chest.

[5]  S. Schneeweiss,et al.  Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma. , 2006, Clinical therapeutics.

[6]  S. Erickson,et al.  Self-Reported Adherence in Patients with Asthma , 2006, The Annals of pharmacotherapy.

[7]  Susan L Ettner,et al.  The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. , 2006, Archives of internal medicine.

[8]  D. Sin,et al.  Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? – study protocol for a randomized controlled trial [NCT00120978] , 2006, BMC pulmonary medicine.

[9]  J. Newhouse,et al.  Care-Seeking Behavior in Response to Emergency Department Copayments , 2005, Medical care.

[10]  P. Jones,et al.  Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma in adults and children. , 2005, The Cochrane database of systematic reviews.

[11]  C. Lemière,et al.  A cohort study showed that health insurance databases were accurate to distinguish chronic obstructive pulmonary disease from asthma and classify disease severity. , 2005, Journal of clinical epidemiology.

[12]  Christine C Johnson,et al.  Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. , 2004, The Journal of allergy and clinical immunology.

[13]  D. Sin,et al.  Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis. , 2004, JAMA.

[14]  Lisa I. Iezzoni,et al.  Risk Adjustment of Medicare Capitation Payments Using the CMS-HCC Model , 2004, Health care financing review.

[15]  R. Pauwels,et al.  Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma. , 2003, The Journal of allergy and clinical immunology.

[16]  Harold I Feldman,et al.  Modifiable barriers to adherence to inhaled steroids among adults with asthma: it's not just black and white. , 2003, The Journal of allergy and clinical immunology.

[17]  M. Halpern,et al.  Asthma: resource use and costs for inhaled corticosteroid vs leukotriene modifier treatment--a meta-analysis. , 2003, The Journal of family practice.

[18]  T. Lieu,et al.  Misunderstanding of Asthma Controller Medications: Association with Nonadherence , 2003, The Journal of asthma : official journal of the Association for the Care of Asthma.

[19]  G. Hackbarth,et al.  Report to the Congress: Medicare Payment Policy , 2003 .

[20]  D. Malone,et al.  Fluticasone Is Associated with Lower Asthma‐Related Costs than Leukotriene Modifiers in a Real‐World Analysis , 2002, Pharmacotherapy.

[21]  S F Paul Man,et al.  Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. , 2002, Archives of internal medicine.

[22]  F. Simons,et al.  Income-based drug benefit policy: impact on receipt of inhaled corticosteroid prescriptions by Manitoba children with asthma. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[23]  R. Pauwels,et al.  Low-dose inhaled corticosteroids and the prevention of death from asthma. , 2000, The New England journal of medicine.

[24]  J. Tu,et al.  Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics. , 2001, The European respiratory journal.

[25]  S. Adlis,et al.  Effect of salmeterol on patients' adherence to their prescribed refills for inhaled corticosteroids. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[26]  M. Bala,et al.  Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. , 2000, Chest.

[27]  D. Faulds,et al.  Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma. , 2000, PharmacoEconomics.

[28]  N Krieger,et al.  Re: "Use of census-based aggregate variables to proxy for socioeconomic group: evidence from national samples". , 1999, American journal of epidemiology.

[29]  J. Boivin,et al.  First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma , 1998, Thorax.

[30]  J Bound,et al.  Use of census-based aggregate variables to proxy for socioeconomic group: evidence from national samples. , 1998, American journal of epidemiology.

[31]  R. Zuwallack,et al.  Adherence with twice-daily dosing of inhaled steroids. Socioeconomic and health-belief differences. , 1998, American journal of respiratory and critical care medicine.

[32]  W. Busse,et al.  Efficacy and safety of inhaled corticosteroids. New developments. , 1998, American journal of respiratory and critical care medicine.

[33]  T. Harris,et al.  Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less. , 1998, Respiratory medicine.

[34]  Donald Rubin,et al.  Estimating Causal Effects from Large Data Sets Using Propensity Scores , 1997, Annals of Internal Medicine.

[35]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[36]  N. Krieger.  Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. , 1992, American journal of public health.

[37]  R. Zuwallack,et al.  A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. , 1992, Chest.

[38]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .